About Subhasree Kar

Subhasree’s keen interest in financial instruments led her to pursue a career as an investment analyst. After earning a Master’s degree in Economics, she gained knowledge of equity research and portfolio management at Finlatics. She uses her knowledge as a fundamental analyst to help investors make informed decisions in regards to their investment portfolios.


Recent Articles By Subhasree Kar

: MCD |  News, Ratings, and Charts

McDonald's (MCD) Earnings Beat: Buy or Sell?

McDonald's (MCD) third-quarter earnings and revenue beat the consensus estimates as strategic price hikes boosted sales. So, is the stock a buy this month? Let’s discuss...
: INTC |  News, Ratings, and Charts

Intel Corporation (INTC) Post-Earnings Analysis: Is It Time to Buy the Stock?

Intel Corporation (INTC) beat the consensus estimates on the top and bottom line in its last reported quarter. So, is the stock a buy now? Read on...
: REGN |  News, Ratings, and Charts

Regeneron Pharmaceuticals (REGN) Earnings Analysis -- Should Investors Brace for Impact?

Regeneron Pharmaceuticals (REGN) has an impressive revenue and earnings surprise history. So, as the company gears up to post its third-quarter report, is REGN the right pick? Read on...
: CVS |  News, Ratings, and Charts

CVS Health (CVS) Earnings Insights -- Is the Drug Store Stock a Buying Opportunity?

While CVS Health (CVS) has been witnessing some volatility in its share price, the stock looks poised to generate steady returns in the long run, given its solid growth prospects. So, as CVS gears up to release its earnings report, let’s analyze if CVS is worth buying now...
: ABNB |  News, Ratings, and Charts

Airbnb (ABNB) Earnings Spotlight: Is the Travel Stock a Buy or Sell?

Airbnb (ABNB) is currently facing new regulations implemented for short-term rentals, which could impact the company’s growth. However, Street analysts expect stable growth in the last quarter. With the company set to release its third-quarter financial results on November 1, 2023, is the stock a buy today? Read on...
: VZ |  News, Ratings, and Charts

Verizon Communications (VZ) Earnings Analysis: A Telecom Stock to Bet On?

Verizon Communications (VZ) soared to its best day in almost 15 years, following the company reporting better-than-expected results for its most recent quarter. So, does this indicate a buying opportunity? Let’s discuss...
: GOOGL |  News, Ratings, and Charts

Assessing Alphabet (GOOGL) as a Potential Buy This Week

Alphabet (GOOGL) delivered double-digit revenue growth for the first time in over a year in the last reported quarter. Also, given the rebound in advertising, let’s assess GOOGL as a potential buy...
: META |  News, Ratings, and Charts

Meta Platforms (META) Earnings Beat: Is the Internet Behemoth Set for Further Upside?

Meta Platforms (META) reported better-than-expected results for the third quarter, with its revenue registering the fastest growth rate since 2021. So, let’s dig deeper into its fundamentals to gauge its upside potential...
: TSM |  News, Ratings, and Charts

3 High-Performing Chip Stocks – Buy Today

The increasing technological advancements and the rising investment in semiconductor manufacturing are expected to drive growth in the market. Thus, it will be wise to buy up high performing chip stocks like Taiwan Semiconductor (TSM), inTest (INTT) and Broadcom (AVGO) today. Read on...
: JNJ |  News, Ratings, and Charts

3 Pharma Stocks on the Rise - Buy Now

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. Thus, it would be prudent to buy pharma stocks, Sanofi (SNY), Johnson & Johnson (JNJ) and AstraZeneca PLC (AZN). Read on...
Page generated in 1.3248 seconds.